These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27862025)

  • 21. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.
    Roussel MP; Morin M; Gagnon C; Duchesne E
    BMC Musculoskelet Disord; 2019 Mar; 20(1):101. PubMed ID: 30836978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
    Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
    Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.
    Heatwole C; Bode R; Johnson N; Dekdebrun J; Dilek N; Heatwole M; Hilbert JE; Luebbe E; Martens W; Mcdermott MP; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley R
    Muscle Nerve; 2014 Jun; 49(6):906-14. PubMed ID: 24142420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
    Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
    Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1.
    Roussel MP; Hébert LJ; Duchesne E
    Neuromuscul Disord; 2020 Apr; 30(4):283-293. PubMed ID: 32340814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The myotonic dystrophy health index: Japanese adaption and validity testing.
    Mori I; Fujino H; Matsumura T; Takada H; Ogata K; Nakamori M; Innami K; Shingaki H; Imura O; Takahashi MP; Heatwole C
    Muscle Nerve; 2019 May; 59(5):577-582. PubMed ID: 30681157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.
    Landfeldt E; Edström J; Jimenez-Moreno C; van Engelen BGM; Kirschner J; Lochmüller H
    Patient; 2019 Aug; 12(4):365-373. PubMed ID: 30714084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to capture activities of daily living in myotonic dystrophy type 2?
    Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
    Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Myotonic Dystrophy Type I patient with Predominant Proximal Muscle Weakness without Action Myotonia- A Case Report and Review of Pathology.
    Wu CI; Chien YY; Lee KY
    Acta Neurol Taiwan; 2021 Sep; 30(3)():113-118. PubMed ID: 34841507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1.
    Knak KL; Sheikh AM; Andersen H; Witting N; Vissing J
    Neurology; 2020 Jun; 94(24):e2508-e2520. PubMed ID: 32457208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remote assessment of myotonic dystrophy type 1: A feasibility study.
    Hamel J; Creigh PD; Dekdebrun J; Eichinger K; Thornton CA
    Muscle Nerve; 2022 Sep; 66(3):336-339. PubMed ID: 35426155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1.
    Serra L; Silvestri G; Petrucci A; Basile B; Masciullo M; Makovac E; Torso M; Spanò B; Mastropasqua C; Harrison NA; Bianchi ML; Giacanelli M; Caltagirone C; Cercignani M; Bozzali M
    JAMA Neurol; 2014 May; 71(5):603-11. PubMed ID: 24664202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1.
    Raymond K; Auger LP; Cormier MF; Vachon C; St-Onge S; Mathieu J; Noreau L; Gagnon C
    Neuromuscul Disord; 2015 Jun; 25(6):522-9. PubMed ID: 25953319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.
    Chisari C; Bertolucci F; Dalise S; Rossi B
    J Neuroeng Rehabil; 2013 Aug; 10():94. PubMed ID: 23938156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness of performance-based outcome measures for mobility, balance, muscle strength and manual dexterity in adults with myotonic dystrophy type 1.
    Kierkegaard M; Petitclerc É; Hébert LJ; Mathieu J; Gagnon C
    J Rehabil Med; 2018 Feb; 50(3):269-277. PubMed ID: 29260836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.
    Gagnon C; Petitclerc É; Kierkegaard M; Mathieu J; Duchesne É; Hébert LJ
    J Neurol; 2018 Jul; 265(7):1698-1705. PubMed ID: 29785524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1.
    Esposito F; Cè E; Rampichini S; Limonta E; Venturelli M; Monti E; Bet L; Fossati B; Meola G
    Neuromuscul Disord; 2016 Jan; 26(1):60-72. PubMed ID: 26520850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability.
    Laberge L; Gagnon C; Jean S; Mathieu J
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1403-5. PubMed ID: 16170085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.